The Role of Lipoprotein-Associated Phospholipase A2Activity and High Sensitivity C-Reactive Protein in Identifying High Risk Smokers for Incident Atherosclerotic Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study

被引：0
|
作者：
Tibuakuu, Martin
Kianoush, Sina
DeFilippis, Andrew P.
McEvoy, William
Zhao, Di
Guallar, Eliseo
Ballantyne, Christie M.
Hoogeveen, Ron C.
Blaha, Michael J.
Michos, Erin D.
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Smoking; Atherosclerosis; Myocardial infarction; Stroke; Inflammation and inflammatory markers;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
14073
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The role of lipoprotein-associated phospholipase A2 on cardiovascular disease risk assessment and plaque rupture: a clinical review
    Reddy, Kota J.
    Singh, Manmeet
    Bangit, Joey R.
    Batsell, Richard R.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2009, 3 (02) : 85 - 93
  • [22] Lipoprotein-associated phospholipase A2 activity improves risk discrimination of incident coronary heart disease among women
    Hatoum, Ida J.
    Cook, Nancy R.
    Nelson, Jeanenne J.
    Rexrode, Kathryn M.
    Rimm, Eric B.
    AMERICAN HEART JOURNAL, 2011, 161 (03) : 516 - 522
  • [23] Cholesterol, Lipoproteins, High-sensitivity C-reactive Protein, and Other Risk Factors for Atherosclerosis
    Rudolf, Joseph
    Lewandrowski, Kent B.
    CLINICS IN LABORATORY MEDICINE, 2014, 34 (01) : 113 - +
  • [24] Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria
    Miller, Rachel G.
    Costacou, Tina
    Orchard, Trevor J.
    DIABETES & VASCULAR DISEASE RESEARCH, 2010, 7 (01) : 47 - 55
  • [25] High-sensitivity C-reactive protein as a biomarker of risk in coronary artery disease
    Silva, Doroteia
    de Lacerda, Antonio Pais
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2012, 31 (11) : 733 - 745
  • [26] High-sensitivity C-reactive protein in children at risk for coronary artery disease
    Guran, Omer
    Akalin, Figen
    Ayabakan, Canan
    Dereli, Feyza Yagmur
    Haklar, Goncagul
    ACTA PAEDIATRICA, 2007, 96 (08) : 1214 - 1219
  • [27] Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors
    Saito, M
    Ishimitsu, T
    Minami, J
    Ono, H
    Ohrui, M
    Matsuoka, H
    ATHEROSCLEROSIS, 2003, 167 (01) : 73 - 79
  • [28] High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study
    Hald, Erin M.
    Braekkan, Sigrid K.
    Mathiesen, Ellisiv B.
    Njolstad, Inger
    Wilsgaard, Tom
    Brox, Jan
    Hansen, John-Bjarne
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (08): : 1189 - 1194
  • [29] Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke - The Rotterdam Study
    Oei, HHS
    van der Meer, IM
    Hofman, A
    Koudstaal, PJ
    Stijnen, T
    Breteler, MMB
    Witteman, JCM
    CIRCULATION, 2005, 111 (05) : 570 - 575
  • [30] Serum High-Sensitivity C-Reactive Protein Levels and the Risk of Atrial Fibrillation in Japanese Population: the Circulatory Risk in Communities Study
    Tanaka, Mari
    Imano, Hironori
    Kubota, Yasuhiko
    Yamagishi, Kazumasa
    Umesawa, Mitsumasa
    Muraki, Isao
    Cui, Renzhe
    Hayama-Terada, Mina
    Shimizu, Yuji
    Okada, Takeo
    Ohira, Tetsuya
    Sankai, Tomoko
    Tanigawa, Takeshi
    Sato, Shinichi
    Kitamura, Akihiko
    Kiyama, Masahiko
    Iso, Hiroyasu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2021, 28 (02) : 194 - 202
12345